Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 7, 2007, Pages 730-732

  Verma, S K ^a   Ahmad, Sohaib ^a   Shirazi, Nadia ^a   Kusum, Anuradha ^a   Kaushik, R M ^a   Barthwal, S P ^a  

^a HIMALAYAN INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Diagnosis; Drug resistance; Epidemiology; India; Sodium stibogluconate; Visceral leishmaniasis

Indexed keywords

STIBOGLUCONATE SODIUM;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DRUG SENSITIVITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INDIA; MALE; TREATMENT OUTCOME; VECTOR CONTROL; VISCERAL LEISHMANIASIS;

ADULT; AGED; ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; DISEASE OUTBREAKS; DRUG RESISTANCE; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED;

EID: 34248327543     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.02.008     Document Type: Article

References (5)

1. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 239-243
2. Dube A., Singh N., Sundar S., and Singh N. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitol. Res. 96 (2005) 216-223
3. Rao J.S., Sharma S.K., Bhattacharya D., and Saxena N.B. Sandfly survey in Nainital and Almora districts of Uttaranchal with particular reference to Phlebotomus argentipes, vector of kala-azar. J. Commun. Dis. 33 (2001) 7-11
4. Singh S., Biswas A., Wig N., Aggarwal P., Sood R., and Wali J.P. A new focus of visceral leishmaniasis in sub-Himalayan (Kumaon) region of northern India. J. Commun. Dis. 31 (1999) 73-77
5. Sundar S. Diagnosis of kala-azar-an important stride. J. Assoc. Physician India 51 (2003) 753